Meinian Onehealth Healthcare Holdings Third Quarter 2024 Earnings: EPS: CN¥1.22 (vs CN¥0.062 in 3Q 2023)

Meinian Onehealth Healthcare Holdings (SZSE:002044) Third Quarter 2024 Results

Key Financial Results

• Revenue: CN¥2.94b (up 4.4% from 3Q 2023).
• Net income: CN¥240.4m (up 12% from 3Q 2023).
• Profit margin: 8.2% (up from 7.7% in 3Q 2023). The increase in margin was driven by higher revenue.
• EPS: CN¥1.22 (up from CN¥0.062 in 3Q 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Meinian Onehealth Healthcare Holdings Earnings Insights

Looking ahead, revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare industry in China.

Performance of the Chinese Healthcare industry.

The company's shares are up 19% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on Meinian Onehealth Healthcare Holdings' balance sheet health.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.